News: Cadila Pharmaceuticals names Ashraf Allam as its global COO

Appointments

Cadila Pharmaceuticals names Ashraf Allam as its global COO

Ashraf Allam comes with close to 30 years of experience in the pharma, biotech, /medical devices and consumer health industries.
Cadila Pharmaceuticals names Ashraf Allam as its global COO

 Cadila Pharmaceuticals has appointed Ashraf Allam as its new global Chief Operating Officer (COO). 

Before joining Cadila, Allam worked with Public Investment Fund as CEO. He has also worked with Johnson & Johnson, Amgen, Eli Lilly, BMS and Mundipharma.

With close to 30 years of experience, Allam started his career as General Manager at Al-Riyadh Governorate, Saudi Arabia.

He has expertise in pharma,biotech, medical devices and consumer health industries. His other expertise lies in start-up operations for listed and privately owned multinational companies, profit and loss management in Europe and emerging markets operations. Corporate development, licensing, acquisitions and integration, raising external funding and executing deals with international investors among others.

He has a Bachelor’s degree in Clinical Pharmaceuticals from Egypt.

Read full story

Topics: Appointments

Did you find this story helpful?

Author

QUICK POLL

What is your top focus area for reinventing work in the hybrid world of work?

How can we prepare for a challenging 2023?

READ our latest issue for tips and suggestions.